Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
PDS Biotechnology Corp (EDGE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/29/2019 |
8-K
| Quarterly results |
| 10/22/2019 |
8-K
| Quarterly results |
| 03/04/2019 |
8-K
| Quarterly results |
| 11/26/2018 |
8-K
| Investor presentation|
Docs:
|
"EDGE THERAPEUTICS, INC.,",
"Form of Support Agreement, by and among Edge Therapeutics, Inc., Echos Merger Sub, Inc., PDS Biotechnology Corporation and certain of PDS Biotechnology Corporation’s directors, officers and stockholders",
"Form of Support Agreement, by and among Edge Therapeutics, Inc., Echos Merger Sub, Inc., PDS Biotechnology Corporation and certain of Edge Therapeutics, Inc.’s directors, officers and stockholders",
"BERKELEY HEIGHTS, N.J. and NORTH BRUNSWICK, N.J.,",
"Unique Multiple Mechanisms of Action Promote In-vivo Killer T-cell Induction Priming and" |
|
| 02/15/2018 |
8-K
| Investor presentation |
| 01/08/2018 |
8-K
| Investor presentation |
| 12/13/2017 |
8-K/A
| Investor presentation |
| 12/13/2017 |
8-K
| Investor presentation |
| 10/28/2015 |
8-K
| Investor presentation |
|
|